Literature DB >> 12373045

Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy.

C M Schannwell1, M Schneppenheim, S Perings, G Plehn, B E Strauer.   

Abstract

AIMS/HYPOTHESIS: Early determination of myocardial manifestations of diabetes mellitus is of major importance, since myocardial involvement considerably influences the prognosis of diabetic patients. The aim of this study was to investigate whether young patients with insulin-dependent diabetes mellitus and normal systolic left ventricular (LV) function already show a diastolic LV dysfunction and an increased risk of arrhythmias.
METHODS: Echocardiography was performed in 87 patients suffering from type I diabetes mellitus, without known cardiac disease and in 87 controls. Patients with a known manifest cardiac disease or a long-term diabetic syndrome were excluded. Morphological parameters were determined using M-mode echocardiography. Doppler echocardiography was used to evaluate parameters of LV diastolic function. The risk of arrhythmia was assessed by means of electrocardiography, heart rate variability, and late potential analysis.
RESULTS: The left atrial and ventricular dimensions and systolic functional parameters of all patients were normal. A diastolic dysfunction with a reduction in early diastolic filling, an increase in atrial filling, an extension of isovolumetric relaxation and deceleration time was documented in diabetic patients, as well as an increased number of supraventricular and ventricular premature beats.
CONCLUSION: Even young patients with diabetes mellitus suffer from a diastolic dysfunction while systolic ventricular function is normal. Therefore, echocardiography with measurements of diastolic functional parameters appears to be a sensitive method for evaluating the manifestation and course of early diabetic cardiomyopathy. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12373045     DOI: 10.1159/000064682

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  94 in total

1.  [Aerobic and strength training in patients with diabetes mellitus type 2 and heart failure].

Authors:  D Niederseer; J Niebauer
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

2.  Is obesity predictive of cardiovascular dysfunction independent of cardiovascular risk factors?

Authors:  E DeVallance; S B Fournier; D A Donley; D E Bonner; K Lee; J C Frisbee; P D Chantler
Journal:  Int J Obes (Lond)       Date:  2014-06-24       Impact factor: 5.095

Review 3.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.

Authors:  Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

4.  Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes.

Authors:  Véronique A Lacombe; Serge Viatchenko-Karpinski; Dmitry Terentyev; Arun Sridhar; Sitaramesh Emani; John D Bonagura; David S Feldman; Sandor Györke; Cynthia A Carnes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-08-29       Impact factor: 3.619

5.  Left bundle branch block in type 2 diabetes mellitus: a sign of advanced cardiovascular involvement.

Authors:  Eliscer Guzman; Narpinder Singh; Ijaz A Khan; Andreas P Niarchos; Cherian Verghese; Cesare Saponieri; Harinder K Singh; Ramesh M Gowda; Balendu C Vasavada; Ronny A Cohen
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

Review 6.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

Review 7.  The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.

Authors:  Joel D Schilling
Journal:  Antioxid Redox Signal       Date:  2015-04-15       Impact factor: 8.401

8.  Diabetic cardiomyopathy: ongoing controversies in 2012.

Authors:  P M Seferović; I Milinković; A D Ristić; J P Seferović Mitrović; K Lalić; A Jotić; V Kanjuh; N Lalić; B Maisch
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

9.  The importance of speckle tracking echocardiography in the early detection of left ventricular dysfunction in patients with polycystic ovary syndrome.

Authors:  Selami Demirelli; Husnu Degirmenci; Emrah Ermis; Sinan Inci; Gokay Nar; Mehmet Emin Ayhan; Serdar Fırtına; Hikmet Hamur; Senay Arikan Durmaz
Journal:  Bosn J Basic Med Sci       Date:  2015-10-19       Impact factor: 3.363

10.  Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Authors:  Karina Huynh; Julie R McMullen; Tracey L Julius; Joon Win Tan; Jane E Love; Nelly Cemerlang; Helen Kiriazis; Xiao-Jun Du; Rebecca H Ritchie
Journal:  Diabetes       Date:  2010-03-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.